NEW YORK (GenomeWeb News) – Genomics services firm BioServe will use biosamples from Philadelphia's Fox Chase Cancer Center to supplement its Global Repository under an exclusive two-year agreement, the Beltsville, Md.-based company said.

The agreement is part of an effort to plug up a "shortage of clinical quality biomaterials" for use in genetic and biomarker-focused cancer research that has caused a bottleneck in biotechnology research, BioServe said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."